Back to search

Article

CENPF Knockdown Inhibits Adriamycin Chemoresistance In Triple Negative Breast Cancer Mediated By Rb-E2F1 Axis

2022-11-07

Abstract excerpt

<title>Abstract</title> <p>Background: Frequent developed resistance leads to early relapse and short survival in Triple-negative breast cancer (TNBC). Targeting DNA damage response (DDR) has become an effective strategy for overcoming TNBC chemoresistance. CENPF (centromere protein) is a key regulator of cell cycle progression, but its role in TNBC chemotherapy resistance remains unclear. <h4>Methods:</h4> We U...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
59ef2b41-91ce-53dc-ab4e-29e7652825e7
DOI
10.21203/rs.3.rs-1853542/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CENPF Knockdown Inhibits Adriamycin Chemoresistance In Triple Negative Breast Cancer Mediated By Rb-E2F1 AxisDOI 10.21203/rs.3.rs-1853542/v2
Select a neighboring publication to make it the new centre.